Innovation is urgent and direly needed as pediatric cancers remain the leading disease-based cause of pediatric death in the United States. OS Therapies is empowered to continue its groundbreaking ...
Regenerative Medicine Advanced Therapy (RMAT) designation requests update submitted to FDA with recent biomarker data ...
Partnership now welcomes Berkeley alumni and idea-stage ventures, reinforcing commitment to supporting AI innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results